REPROS THERAPEUTICS INC.: cashflow_investing
| Value | {"amount": 0, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2014-01-01 – 2014-03-31 |
| Status | current |
| Entity | REPROS THERAPEUTICS INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:01:54.332042+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/ae224972-6990-4e68-a868-a2bcbbbe3df1
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001144204-15-028236 · Open the official SEC filing →Retrieved: 2026-08-19T09:01:54.332042+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000897075/cashflow-investing/2014-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/ae224972-6990-4e68-a868-a2bcbbbe3df1
History
- supersedes {"amount": -285000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} (evidence 0001144204-14-029339)